SEC Enforcement Actions Against Companies for Misleading COVID-19 Claims
Harvard Law School Forum on Corporate Governance, the top online resource for discourse on corporate governance, recently published a securities law blog post authored by partner Kenneth Silverman and associates Robert Gagne and Morgan Spina. The article “SEC Enforcement Actions Against Companies for Misleading COVID-19 Claims” addresses how actions taken by the U.S. Securities and Exchange Commission are consistent with approaches taken by other regulators, including the Federal Trade Commission and Food and Drug Administration, with regard to misleading statements made in connection with coronavirus-related products. On the whole, regulators appear to be particularly cognizant of businesses and individuals seeking to take improper advantage of the circumstances created by the global pandemic, and as such are taking action against such companies and individuals. The article can be viewed in its entirety here.